id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-V-3373-0003,FDA,FDA-2022-V-3373,Variance Approval Letter from FDA CDRH to 4Grand Entertainment,Other,Approval for Variance (VRA),2023-02-24T05:00:00Z,2023,2,2023-02-24T05:00:00Z,,2023-02-24T18:37:27Z,,0,0,09000064857011ba